DDT exposure raises ALL women's risks of breast cancer 40 years later, study finds

The now-banned pesticide DDT is a suspected carcinogen, but was once widespread. New research from the Public Health Institute suggests women's breast cancer risks spike 40 years post-exposure.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Publication date: June 2019Source: Biomedicine &Pharmacotherapy, Volume 114Author(s): Xiwei Ji, Yuan Lu, Huifang Tian, Xiangrui Meng, Minji Wei, William C. ChoAbstractChemoresistance is one of the major challenges for the breast cancer treatment. Owing to its heterogeneous nature, the chemoresistance mechanisms of breast cancer are complicated, and not been fully elucidated. The existing treatments fall short of offering adequate solution to drug resistance, so more effective approaches are desperately needed to improve existing therapeutic regimens. To overcome this hurdle, a number of strategies are being investigate...
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
Publication date: Available online 20 February 2019Source: Practical Radiation OncologyAuthor(s): Elham Rahimy, Joanne Weidhaas, Wei Wei, Donald Lannin, Nina Horowitz, Susan Higgins, Lynn D. Wilson, Christin Knowlton, Meena S. Moran, Melissa Rasar Young, Brigid Killelea, Anees Chagpar, Debra Nana Yeboa, Dan Zelterman, Suzanne EvansAbstractPurposeThree-dimensional conformal accelerated partial breast irradiation (APBI) is a treatment option for well selected women with breast cancer, despite reports of adverse cosmetic outcome with this technique. Dose-volume relationships may be responsible for this poor cosmesis. We aimed...
Source: Practical Radiation Oncology - Category: Cancer & Oncology Source Type: research
The U.S. Department of Justice (DOJ) has shifted its position on the Patient...Read more on AuntMinnie.comRelated Reading: ACA has benefited low- and middle-income women How has the ACA affected breast cancer screening? DOJ action may hinder disabled access to imaging More women get breast screening after ACA bans copays Tax reform bill overturns ACA's individual mandate
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Publication date: Available online 25 March 2019Source: Biocybernetics and Biomedical EngineeringAuthor(s): Bikesh Kumar SinghAbstractEarly detection of breast cancer plays crucial role in planning and result of associated treatment. The purpose of this article is threefold: (i) to investigate whether or not clinical features obtained using routine blood analysis combined with anthropometric measurements can be utilized for envisaging breast cancer using predictive machine learning techniques; (ii) to explore the role of various machine learning components such as feature selection, data division protocols and classificati...
Source: Biocybernetics and Biomedical Engineering - Category: Biomedical Engineering Source Type: research
A panel of experts convened by the FDA yesterday said that there’s not enough data to pull textured breast implants from the market over concerns that they may be linked to a type of immune system cancer, according to an AP News report. The recommendation comes from the first day of a two-day panel meeting discussing the risks associated with breast implant devices, reviewing current study data and exploring how to best track and treat the cancer, and other issues, the devices have been tied to. The FDA only began reporting on the cancer, known as breast implant-associated anaplastic large cell lymphoma, and its link...
Source: Mass Device - Category: Medical Devices Authors: Tags: Cosmetic/Aesthetic Food & Drug Administration (FDA) Oncology Women's Health Source Type: news
The most comprehensive study yet of this technique found no cases of breast cancer at 53 months, suggesting it is safe.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
In conclusion, DHA inhibits canine mammary tumours cells migration and invasiveness by regulating the expression of EMT-related genes.
Source: Research in Veterinary Science - Category: Veterinary Research Source Type: research
Authors: Tandon M, Ball W, Kirby R, Soumian S, Narayanan S Abstract BACKGROUND: Axillary Ultrasound (AUS) is now performed as a protocol in every newly diagnosed breast cancer in most European countries. It is an inexpensive and sensitive tool in hands of a trained operator. All AUS negative patients undergo Sentinel Lymph Node Biopsy (SLNB), while AUS positive patients bypass SLNB and undergo axillary nodal clearance (ANC) as a standard protocol. We wish to analyse these two groups to see if ANC can be foregone in these patients. AIMS AND OBJECTIVES: To compare and analyse the axillary disease burden in early ...
Source: Breast Disease - Category: Cancer & Oncology Tags: Breast Dis Source Type: research
This study was designed to evaluate the effect of DmdNKΔC20 for sensitizing human cancer cell lines towards gemcitabine and to further investigate its role in reversal of acquired drug resistance in gemcitabine-resistant cancer cell line. The DmdNKΔC20 gene was delivered to three different cancer cell lines, including breast, colon and liver cancer cells, using lipid-mediated transfection reagent. After transfection, gene expression of DmdNKΔC20 was confirmed by reverse transcription quantitative PCR (qRT-PCR) and the combined effect of DmdNKΔC20 and gemcitabine based cytotoxicity was observed by ce...
Source: Bosnian Journal of Basic Medical Sciences - Category: General Medicine Tags: Bosn J Basic Med Sci Source Type: research
By BISHAL GYAWALI MD, PhD Hey, I’m back! Well, you might not have noticed that my blogs were missing for the last three months but anyways, its good to be back. I was having a little time off blogs and social media as I was transitioning in my career but now I am back. Sometimes, it is very difficult to manage time for things that you must do versus things you enjoy doing, especially when these two don’t intersect. For me, these last few months the things I had to do were all bureaucratic while I couldn’t find the time for things I enjoy doing like writing these blogs. But now that we are back,...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Medical Practice Physicians Bishal Gyawali Cancer drugs Clinical Trials Oncology Prostate Cancer RCTs Source Type: blogs
More News: Breast Cancer | Cancer | Cancer & Oncology | Health | International Medicine & Public Health | Study | Women